The stock of Applied Therapeutics Inc (NASDAQ:APLT) last traded at $4.67, up 1.52% from the previous session.
APLT stock price is now 3.60% away from the 50-day moving average and 23.56% away from the 200-day moving average. The market capitalization of the company currently stands at $533.64M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $12, RBC Capital Mkts recently initiated with Outperform rating for Applied Therapeutics Inc (NASDAQ: APLT). On February 22, 2024, Leerink Partners recently initiated its ‘Outperform’ rating on the stock quoting a target price of $12, while ‘Barclays’ rates the stock as ‘Equal Weight’
In other news, Shendelman Shoshana, President and CEO sold 61,795 shares of the company’s stock on Jun 06 ’24. The stock was sold for $266,954 at an average price of $4.32. Upon completion of the transaction, the President and CEO now directly owns 3,756,019 shares in the company, valued at $17.54 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 06 ’24, Chief Medical Officer Perfetti Riccardo sold 22,003 shares of the business’s stock. A total of $95,053 was realized by selling the stock at an average price of $4.32. This leaves the insider owning 1,009,534 shares of the company worth $4.71 million. A total of 22.81% of the company’s stock is owned by insiders.
During the past 12 months, Applied Therapeutics Inc has had a low of $1.18 and a high of $9.39. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 1.80, and a quick ratio of 1.80. The fifty day moving average price for APLT is $4.5047 and a two-hundred day moving average price translates $3.794975 for the stock.
The latest earnings results from Applied Therapeutics Inc (NASDAQ: APLT) was released for 2024-03-31. The net profit margin was -905.38% and return on equity was -682.16% for APLT. The company reported revenue of $0.19 million for the quarter, compared to $10.66 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -98.22 percent.
